Keep up to date
In the press | 01.04.2019
Reinventing the Biomanufacturing Wheel
Our Product Manager Tania explains the challenges in biologic manufacturing and Univercells' solutions in BioParhm International article
Univercells news | 27.03.2019
Univercells joins the Belgian State Visit to South Korea
Belgian State Visit to Korea - Hugues Bultot, CEO of Univercells, joins the Belgian business delegation to strengthen and further ...
Univercells news | 21.02.2019
Univercells presents NevoLine™ biomanufacturing system
Based on a novel process architecture, Univercells designed the automated NevoLine bioproduction system that facilitates safer, faster and closed bioprocessing ...
In the press | 14.02.2019
A Brief History of Adherent Cell Culture
Our Product Manager Alex Chatel explains the evolution of cell culture from the materials used - suspension cells to adherent cells ...
Univercells news | 05.02.2019
Univercells presents its scale-X bioreactor system for viral vectors production
Univercells presents its scale-X bioreactor system for viral vectors production with a proof of concept with HEK293 cell growth & ...
Press release | 11.01.2019
Univercells introduces breakthrough vaccine manufacturing platform
Univercells announces today the commercial launch of its proprietary NevoLine™ bioproduction system for vaccines.
In the press | 01.11.2018
Scaling up Novel Therapies
Our Product Manager Alex chatel and other peers from the industry discuss about technologies used to improve scale-up and the challenges ...
Univercells news | 10.09.2018
Univercells welcomes Pierre Morgon as member of the Board of Directors
Dr. Pierre Morgon brings his notable experience and extensive industry knowledge to reinforce Univercells’ business strategy and ...